Do Google, Meta and TikTok allow peptide and GLP-1 ads?
Yes, for a certified, prescriber-led business, and no for anyone selling peptides outside a prescription. This post is part of our peptide advertising compliance guide. It covers only what each platform's own policy pages said when we read them on October 4, 2026. Platform policies change without notice, so check the linked page before you rely on any line below.
| Rule (as of October 2026) | Google Ads | Meta | TikTok |
|---|---|---|---|
| Prescription drug ads in the US | Allowed for certified advertisers. Online pharmacies need LegitScript or NABP accreditation, telemedicine providers need LegitScript, and both need Google certification.[1] | Online pharmacies and telehealth providers need active LegitScript certification plus Meta authorization. US, Canada or New Zealand only.[11] | May be allowed in the US and Canada if the drug is approved by the regulator and the ad targets 18+.[16] |
| Age targeting | Not covered in the policies cited here | 18+ for prescription drug ads and for weight-loss, dietary and health products.[11][13] | 18+ for prescription drugs and for weight-loss or muscle-gain claims.[15][16] |
| Unapproved drugs | Prohibited, under a non-exhaustive list.[5] | Unsafe substances prohibited at Meta's sole discretion.[11] | Drugs for enhancement, performance and weight loss not allowed.[16] |
| Weight-loss creative | Not covered in the policies cited here | No appearance-shaming, no pinched-fat close-ups.[13] | Restricted: healthy lifestyle, no unrealistic or guaranteed results.[15] |
| Landing page reviewed | Yes[2] | May be[14] | Rules apply to landing pages[15] |
What does Google Ads require?
Google's Healthcare and medicines policy sets out three separate questions: whether you may advertise prescription drug services at all, whether you may use drug names, and whether the product is on the prohibited side of the line.
Certification for prescription drug services
Google says that "Advertisers must be certified in order to serve ads for prescription drug services," and allows that promotion in 32 listed countries, including the United States. In the US, Google allows online pharmacies accredited by the LegitScript Healthcare Merchant Certification Program or the National Association of Boards of Pharmacy (NABP). It allows telemedicine providers only if they hold LegitScript certification. Google certification is required on top of either.[1]
Drug names in ads and on landing pages
Semaglutide, liraglutide and tirzepatide are on Google's list of prescription drug terms. For the US, Canada and New Zealand, Google's restricted drug terms policy says you do not need certification to use prescription drug terms in ads and landing pages, but you must be certified to keyword-target them. In every other country, prescription drug terms may not appear in ads or landing pages at all.
Unapproved substances
Google's unapproved substances policy prohibits promoting items on its list of unapproved pharmaceuticals and supplements, "regardless of any claims of legality." The list itself says it is not exhaustive and names branded products. It names no peptide. The policy reaches further than the list, though. It also covers products that imply they are as effective as prescription drugs, non-government-approved products marketed as safe or effective to prevent, cure or treat a disease, and products that have been subject to government or regulatory action or warning. An unapproved peptide marketed for human use can fall under that wording without being named.
YouTube ads follow the same rules. YouTube says advertisers must comply with Google's ad policies, including Healthcare and medicines. Separately, YouTube's regulated goods policy does not allow content that sells pharmaceuticals without a prescription, and says a channel that links to such sellers may be terminated.
Which Google violations are egregious, and which get a warning?
Google enforces these policies differently, and the difference matters more than any single rule.
| Google policy (as of October 2026) | What it covers | Enforcement |
|---|---|---|
| Unauthorized pharmacies | Offering prescription drugs without a prescription, and targeting locations where you are not licensed | Egregious Accounts suspended on detection, without prior warning, and no return to Google Ads[7] |
| Unapproved substances | Unapproved pharmaceuticals and supplements, and the catch-all categories above | Warning first At least 7 days' warning before any suspension[5] |
| Prescription drug services | Promoting prescription drugs or services without certification | Warning first At least 7 days' warning[2] |
| Speculative and experimental medical treatment | Treatments Google classes as speculative or experimental | Warning first At least 7 days' warning[8] |
The egregious category is the one the research-peptide checkout model runs into. A site that lets anyone buy semaglutide or retatrutide without a prescription is offering prescription drugs without a prescription. Google's unauthorized pharmacies policy calls such violations "egregious" and says Google may review "your ad, website, accounts, and third-party sources."
What are Meta's rules for prescription and weight-loss ads?
Prescription drugs and telehealth
Meta's Drugs and Pharmaceuticals policy says: "Meta requires online pharmacies and telehealth providers to be actively certified with LegitScript. Once they have a LegitScript certification, they must request authorization from Meta." Those ads may run only in the United States, Canada or New Zealand, must target people 18 or older, and must include a disclaimer to consult a licensed health professional or obtain a valid prescription. Meta does not require written authorization for ads that promote telehealth services generally, or that educate about prescription drugs. Meta also prohibits ads that promote "illicit or recreational drugs, or other unsafe substances, products or supplements, as determined by Meta at its sole discretion." That page names no peptide.
Personal attributes
Meta's personal attributes policy bars ads that assert or imply a viewer's physical or mental health, including medical conditions. Meta's own examples: "Do you have diabetes?" is not allowed, and "New diabetes treatment available" is allowed. In our reading, a clinic ad that opens with "Struggling with your weight?" follows the same pattern.
Weight-loss creative
Meta's Health and Wellness policy, as of the change log entry dated July 22, 2026, requires weight-loss, dietary and health product ads to target people 18 or older. It bars statements of inferiority about physical appearance, close-ups of a body area showing pinched fat, and promises of specific outcomes within a set timeframe without disclaimers or qualifiers. For adult audiences, dietary weight-loss ads may show people using the product and its impact, and must clearly indicate the time taken to achieve noticeable results. Prescription weight-loss products are sent back to the Drugs and Pharmaceuticals policy above.
What are TikTok's rules?
TikTok's dangerous products policy does not allow ads for "Illegal drugs, controlled drugs, prescription drugs, and drugs for the purpose of recreation, homeopathy, enhancement, performance, and weight loss," or for unauthorized pharmacies. It then carves out prescription drugs in Canada and the United States if the drug is approved by the regional regulating authority, the ad makes no misleading claims, and it targets 18+. TikTok's healthcare and pharmaceuticals policy asks US prescription drug advertisers for proof of approval from a regulator such as the FDA, and asks pharmacies for proof of certification from NABP, LegitScript or a regional equivalent.
TikTok does not address compounded drugs by name. Its condition is regulator approval, and the FDA states that compounded drugs are not FDA-approved. Read together, a compounded GLP-1 does not meet that condition as written. That is our reading, not a TikTok statement.
Weight management is restricted, not banned. TikTok's weight management policy says weight-loss or muscle-gain claims must target 18+ and do so "via the promotion of a healthy lifestyle." It does not allow references to unrealistic results, claims that a product alone without diet or exercise leads to weight loss, or suggestions that weight loss is easy or guaranteed. It also says ad content and landing pages must not shame users about their bodies or suggest there is an ideal body type.
What is LegitScript certification, and who needs it?
LegitScript certification is what Google requires of US telemedicine advertisers and what Meta requires of online pharmacies and telehealth providers promoting prescription drugs. TikTok accepts it as one pharmacy certification. LegitScript's own page names Google, Microsoft, Meta and TikTok as platforms that recognize it.
Its certification standards explain why a research-peptide seller cannot use it. Standard 2 says a business "must not facilitate the prescribing or dispensing of medications that do not hold the necessary authorization or approval from the applicable regulatory body." Standard 7 says no prescription may be issued or filled "prior to the provision of care by a licensed medical professional." Standard 4 says partner pharmacies are generally required to be LegitScript-certified or accredited by another recognized body. Standard 9 says advertising in apparent violation of a platform's terms may be grounds for denial or revocation, so a clinic that breaks platform rules can lose the certification those platforms require.
LegitScript does certify compounding pharmacies. Its application questions include a compounding addendum about USP 795 and 797. No standard says compounded drugs are certifiable as a category. The test in the standards is legality.
Do ad platforms review the landing page?
Yes. Google says it decides whether you are promoting prescription drug services from "the content of your ads, site, or app," and that it "errs on the side of caution" with landing pages that appear to facilitate online prescription or sale of medicines. Meta says its review may include "an ad's destination, like a landing page or website." TikTok's body-image rules apply to landing pages by name.[15]
The FDA reads the same pages. Its warning letters to peptide sellers cite blog posts as labeling, such as the letter dated August 24, 2026 to Royal Peptides LLC, and social media testimonials, such as the letter dated December 10, 2024 to Prime Vitality, Inc. dba Prime Peptides. A clean ad that sends traffic to a non-compliant page fails both reviews. Our post on why "Research Use Only" does not protect a peptide business walks through those letters.
Which common claims about platform rules are wrong?
| Common claim | What the policy says (as of October 2026) |
|---|---|
| "Google blacklists your domain if one peptide name appears on the page." | No Google policy page we checked uses the word "blacklist" or describes a domain ban triggered by one word. Unapproved substances is a warn-first policy, and in the US prescription drug names may appear in ads and on landing pages.[3][5] |
| "Google names BPC-157 as a banned substance." | Google's unapproved list names no peptide. Its catch-all clauses can still reach an unapproved peptide marketed for human use.[5][6] |
| "Meta bans before-and-after images." | Not in the policy as of the change log entry dated July 22, 2026. Cosmetic ads may show before-and-after transformations, and adult-targeted dietary weight-loss ads may show the product's impact with the time taken. Pinched-fat close-ups and inferiority statements remain banned.[13] |
| "Meta automatically rejects syringe imagery." | No Meta ad standard we checked mentions syringes. The Health and Wellness policy allows ads for injectable cosmetic treatments to 18+. Reviewers may still reject a specific creative.[13] |
| "TikTok bans weight-loss ads." | TikTok restricts weight-management ads (18+, healthy lifestyle, no unrealistic or guaranteed results). It does ban ads for weight-loss and enhancement drugs.[15][16] |
| "A 'not for human consumption' disclaimer keeps it compliant." | LegitScript calls that language "often a red flag rather than a legal protection." |
A policy permitting a before-and-after image does not make the image lawful. FTC staff guidance says before-and-after images can convey an implied claim that must be substantiated, and that adding "Results not typical" to dramatic results does not cure the deception. Our post on what a peptide or GLP-1 clinic can and cannot say in ads covers the claim side.
What should a prescriber-led clinic do before launching?
This is our working checklist, built from the policies above. It is not a platform requirement list.
- Get LegitScript certification before any ad that promotes prescription treatment on Google or Meta, then apply for each platform's own certification or authorization.
- Confirm your partner pharmacy is LegitScript-certified or accredited by another recognized body, since LegitScript's Standard 4 generally expects it.
- Make sure no page lets a visitor buy a prescription drug without a prescription. That is the one Google violation with no warning.
- Target 18+ on Meta and TikTok for any health, weight or prescription ad, and limit Meta prescription ads to the US, Canada or New Zealand.
- Rewrite any headline that asserts the viewer's condition ("Do you have...?") before it reaches Meta.
- Review the landing page, blog and social posts with the same care as the ad, because Google and FDA look at the whole site and Meta's review may include the landing page.
- Re-read each platform's policy page before launch and record the date. Payment processors run a parallel review, covered in our post on peptide payment processing and the MATCH list.
Software can enforce part of item 3. In LUKE, a product the clinic flags as requiring a prescription cannot be bought without an active, verified prescription, and the rule is enforced at checkout and in the database. LegitScript and platform certification are separate steps.
Prescription-gated checkout for prescriber-led clinics
LUKE gives clinics prescription-gated checkout for flagged products, intake links and a lead pipeline, and Stripe billing in one platform. Products the clinic flags as prescription-only cannot be bought without an active, verified prescription.
Advertising and marketing services are provided by Ernesto Cullari Media LLC, LUKE's agency partner, under a separate agreement. They are not part of a LUKE software subscription.
Frequently Asked Questions
Can a peptide or GLP-1 clinic advertise on Google?
A certified telehealth provider can. As of October 2026, Google allows US telemedicine providers that hold LegitScript certification and Google's own certification to serve ads for prescription drug services. Online pharmacies need LegitScript or NABP accreditation plus Google certification. A site that offers prescription drugs without a prescription is treated as an egregious violation and suspended without warning.
Does Google ban a website for mentioning a peptide name?
No. As of October 2026, no Google policy page we checked describes a domain ban triggered by one word, and Google's unapproved substances list names no peptide. Unapproved substances is a warn-first policy with at least 7 days' notice before suspension. In the US, prescription drug names such as semaglutide may appear in ads and on landing pages, but keyword-targeting them requires Google certification.
Does Meta still ban before-and-after photos for weight loss?
Not in its current policy. Meta's Health and Wellness policy, as of the change log entry dated July 22, 2026, lets adult-targeted dietary weight-loss ads show the product's impact if they state the time taken, and lets cosmetic ads show before-and-after transformations. It still bars pinched-fat close-ups and statements of inferiority about appearance. FTC guidance on implied claims and typical results still applies to any before-and-after image.
Does TikTok ban weight-loss ads?
TikTok restricts weight-management ads rather than banning them. As of October 2026, claims must target 18+, promote a healthy lifestyle, and avoid unrealistic, easy or guaranteed results. TikTok does not allow ads for drugs for weight loss, enhancement or performance, and allows prescription drug ads in the US and Canada only for regulator-approved drugs targeted at adults.
Do I need LegitScript certification to advertise a telehealth clinic?
To promote prescription treatment, usually yes. As of October 2026, Google requires LegitScript certification for US telemedicine providers, and Meta requires it, plus Meta authorization, for telehealth providers and online pharmacies promoting prescription drugs. Meta does not require authorization for ads that promote telehealth services generally. TikTok accepts NABP, LegitScript or a regional equivalent for pharmacies.
Do ad platforms check my landing page?
Yes. Google judges prescription drug services from your ads, site and app and says it errs on the side of caution with landing pages. Meta says its review may include the landing page. TikTok applies its weight and body-image rules to landing pages. FDA warning letters to peptide sellers also cite website copy, blog posts and social media as evidence of intended use.
Sources
- Google Ads, Healthcare and medicines policy
- Google Ads, Prescription drug services
- Google Ads, Restricted drug terms
- Google Ads, Prescription drug terms list
- Google Ads, Unapproved substances
- Google Ads, Unapproved pharmaceuticals and supplements list
- Google Ads, Unauthorized pharmacies
- Google Ads, Speculative and experimental medical treatment
- YouTube, Advertising policies
- YouTube, Illegal or regulated goods or services
- Meta, Drugs and Pharmaceuticals
- Meta, Personal attributes
- Meta, Health and Wellness
- Meta, Ad policy guidance for small businesses
- TikTok, Weight management
- TikTok, Dangerous products or services
- TikTok, Healthcare and pharmaceuticals
- LegitScript, Healthcare certification standards
- LegitScript, Telemedicine certification
- LegitScript, Healthcare Merchant Certification application questions (2021)
- LegitScript, The growing risk of peptides (October 30, 2025)
- FDA, FDA intends to take action against non-FDA-approved GLP-1 drugs (February 6, 2026)
- FDA warning letter to Royal Peptides LLC (August 24, 2026)
- FDA warning letter to Prime Vitality, Inc. dba Prime Peptides (December 10, 2024)
- FTC staff, Health Products Compliance Guidance (December 2022)